...
首页> 外文期刊>Macromolecular Research >All-trans retinoic acid release from surfactant-free nanoparticles of poly(DL-lactide-co-glycolide)
【24h】

All-trans retinoic acid release from surfactant-free nanoparticles of poly(DL-lactide-co-glycolide)

机译:从无表面活性剂的聚(DL-丙交酯-共-乙交酯)纳米颗粒中释放全反式维甲酸

获取原文
获取原文并翻译 | 示例
           

摘要

In this study, we prepared all-trans retinoic acid (ATRA)-encapsulated, surfactant-free, PLGA nanoparticles. The nanoparticles were formed by nanoprecipitation process, after which the solvent was removed by solvent evaporation or dialysis method. When a nanoparticle was prepared by the nanoprecipitation - solvent evaporation method, the nanoparticles were bigger than the nanoparticles of the nanoprecipitation - dialysis method, despite the higher although loading efficiency. Nanoparticles from the nanoprecipitation - dialysis method were smaller than 200 nm in diameter, while the loading efficiency was not significantly changed. Especially, nanoparticles prepared from DMAc, 1,4-dioxane, and DMF had a diameter of less than 100 nm. In the transmission electron microscopy (TEM) observations, all of the nanoparticles showed spherical shapes. The loading efficiency of ATRA was higher than 90 % (w/w) at all formulations with exception of THF. The drug content was increased with increasing drugfeeding amount while the loading efficiency was decreased. In the drug release study, an initial burst was observed for 2~6 days according to the variations of the formulation, after which the drug was continuously released over one month. Nanoparticles from the nanoprecipitation - dialysis method showed faster drug release than those from the nanoprecipitation — solvent evaporation method. The decreased drug release kinetics was observed at lower drug contents. In the tumor cell cytotoxicity test, ATRA-encapsulated, surfactant-free, PLGA nanoparticles exhibited similar cytotoxicity with that of ATRA itself.
机译:在这项研究中,我们制备了全反式维甲酸(ATRA)封装的不含表面活性剂的PLGA纳米粒子。通过纳米沉淀法形成纳米颗粒,然后通过溶剂蒸发或渗析方法除去溶剂。当通过纳米沉淀-溶剂蒸发方法制备纳米颗粒时,尽管负载效率较高,但是纳米颗粒比纳米沉淀-透析方法的纳米颗粒更大。来自纳米沉淀-透析方法的纳米颗粒的直径小于200nm,而负载效率没有显着改变。特别地,由DMAc,1,4-二恶烷和DMF制备的纳米颗粒的直径小于100nm。在透射电子显微镜(TEM)观察中,所有纳米颗粒均显示球形。在所有配方中,除THF外,ATRA的负载效率均高于90%(w / w)。随着加药量的增加,药物含量增加,而装载效率降低。在药物释放研究中,根据制剂的变化观察到了最初的爆发,持续2到6天,此后连续一个月释放了药物。纳米沉淀-透析方法得到的纳米颗粒比纳米沉淀-溶剂蒸发方法得到的药物释放更快。在较低的药物含量下观察到药物释放动力学降低。在肿瘤细胞的细胞毒性测试中,ATRA封装的不含表面活性剂的PLGA纳米颗粒具有与ATRA自身相似的细胞毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号